A novel method to quantify and characterize leukemia-reactive natural killer cells in patients undergoing allogeneic hematopoietic stem cell transplantation following conventional or reduced-dose conditioning.

Source:http://linkedlifedata.com/resource/pubmed/id/17483077

Download in:

View as

General Info

PMID
17483077